首页 > 市场调查报告书 > 材料

市场调查报告书

商品编码

1451707

2024-2032 年按类型、技术、形式、应用和地区分類的核苷酸市场报告

Nucleotides Market Report by Type, Technology, Form, Application, and Region 2024-2032

出版日期: 2024年03月02日 | 出版商:

IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2023年，全球核苷酸市场规模达到7.184亿美元。展望未来， IMARC Group预计到2032年市场规模将达到12.518亿美元，2024-2032年复合年增长率（CAGR）为6.2%。

核苷酸是核酸的基本组成部分，例如核糖核酸（RNA）和脱氧核糖核酸（DNA）。它们增强各种代谢过程和细胞中合成的蛋白质结构的形成。它们与酵素作用，加速体内的生化反应。它们也透过与嘌呤能受体的相互作用来帮助大分子的生物合成和细胞讯号传导。此外，核苷酸也有助于体内编码、传递和表达遗传讯息。由于核苷酸对疱疹病毒具有高度的效力和选择性，因此在多种药物中用作抗病毒或抗癌剂。

核苷酸市场趋势：

目前，全球范围内优格、炼乳和奶粉等乳製品中核苷酸补充剂的使用量有所增加。这一点，加上这些粉末状液体补充剂的供应量不断增加，是推动市场发展的关键因素之一。除此之外，营养保健品中越来越多地使用核苷酸来治疗营养不良、压力和高血压等疾病，也促进了市场的成长。此外，核苷酸在诊断研究中的应用不断增加，以诊断各种病毒性疾病和癌症类型的存在，正在推动市场的成长。此外，为了维持牲畜的新陈代谢率，动物饲料中对核苷酸的需求也在增加。再加上大众对动物疾病有害影响的认识不断增强，正在对市场产生正面影响。除此之外，对核苷酸的需求不断增加，以促进肠上皮细胞的恢復，有助于增强免疫系统，这提供了积极的市场前景。此外，核糖核苷酸在婴儿食品配方中的使用不断增加也促进了市场的成长。

本报告回答的关键问题：

迄今为止，全球核苷酸市场表现如何，未来几年将如何表现？
COVID-19 对全球核苷酸市场有何影响？
主要区域市场有哪些？
依类型划分市场是怎么样的？
基于技术的市场区隔是什么？
市场的细分是基于什么形式？
基于应用程式的市场区隔是什么？
产业价值链的各个阶段是什么？
该行业的关键驱动因素和挑战是什么？
全球核苷酸市场的结构如何？谁是主要参与者？
产业竞争程度如何？

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 市场细分：按国家/地区
- 市场预测

第 11 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 12 章：价值链分析

第 13 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 14 章：价格分析

第15章：竞争格局

市场结构
关键参与者
关键参与者简介
- CJ CheilJedang Corporation
- Exotic Biosolutions
- F. Hoffmann-La Roche AG
- Jena Bioscience GmbH
- Koninklijke DSM NV
- Lallemand Inc.
- Meridian Bioscience Inc.
- Nanjing Biotogether Co. Ltd.
- Ohly GmbH (Associated British Foods plc)
- Promega Corporation
- Starlake Bioscience Co. Inc.
- Thermo Fisher Scientific Inc.

简介目录图表

Product Code: SR112024A6472

The global nucleotides market size reached US$ 718.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,251.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032.

Nucleotides are the basic building block of nucleic acids, such as ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). They enhance various metabolic processes and the formation of the structure of proteins synthesized in the cell. They act with enzymes to speed up biochemical reactions in the body. They also aid in the biosynthesis of macromolecules and cell signaling through interaction with purinergic receptors. In addition, nucleotides assist in encoding, transmitting, and expressing genetic information in the body. As they provide a high degree of potency and selectivity against the herpes group of viruses, nucleotides are used as antiviral or anticancer agents in several medicines.

Nucleotides Market Trends:

At present, there is a rise in the utilization of nucleotide supplements in dairy products, such as yogurt and condensed and powdered milk, across the globe. This, along with the growing availability of these supplements in the form of powdered fluids, represents one of the key factors driving the market. Besides this, the increasing employment of nucleotides in nutraceuticals to treat conditions, such as poor nutrition, stress, and hypertension, is contributing to the growth of the market. In addition, the rising application of nucleotides in diagnostic research to diagnose the presence of various viral diseases and types of cancer is propelling the growth of the market. Moreover, there is an increase in the demand for nucleotides in animal feed to maintain metabolism rates in livestock. This, coupled with the growing awareness among the masses about the harmful impacts of animal diseases, is positively influencing the market. Apart from this, the escalating demand for nucleotides to enhance the recovery of intestinal epithelial cells, which helps boost the immunity system, is offering a positive market outlook. Additionally, the increasing usage of ribonucleotides in infant food formulations is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleotides market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, form and application.

Breakup by Type:

Food Grade

Lab Grade

Industry Grade

Others

Breakup by Technology:

TaqMan Allelic Discrimination

Gene Chips and Microarrays

SNP by Pyrosequencing

Others

Breakup by Form:

Liquid

Powder

Breakup by Application:

Pharmaceutical

Food and Animal Feed Additives

Drug Discovery

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being CJ CheilJedang Corporation, Exotic Biosolutions, F. Hoffmann-La Roche AG, Jena Bioscience GmbH, Koninklijke DSM N.V., Lallemand Inc., Meridian Bioscience Inc., Nanjing Biotogether Co. Ltd., Ohly GmbH (Associated British Foods plc), Promega Corporation, Starlake Bioscience Co. Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

How has the global nucleotides market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global nucleotides market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the form?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global nucleotides market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Nucleotides Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Food Grade
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Lab Grade
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Industry Grade
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Technology

7.1 TaqMan Allelic Discrimination
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Gene Chips and Microarrays
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 SNP by Pyrosequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Form

8.1 Liquid
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Powder
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Application

9.1 Pharmaceutical
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Food and Animal Feed Additives
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Drug Discovery
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 CJ CheilJedang Corporation
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
- 15.3.2 Exotic Biosolutions
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 F. Hoffmann-La Roche AG
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
- 15.3.4 Jena Bioscience GmbH
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 Koninklijke DSM N.V.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Lallemand Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Meridian Bioscience Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Nanjing Biotogether Co. Ltd.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
- 15.3.9 Ohly GmbH (Associated British Foods plc)
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
- 15.3.10 Promega Corporation
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 Starlake Bioscience Co. Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
- 15.3.12 Thermo Fisher Scientific Inc.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

简介目录图表

List of Figures

Figure 1: Global: Nucleotides Market: Major Drivers and Challenges
Figure 2: Global: Nucleotides Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Nucleotides Market: Breakup by Type (in %), 2023
Figure 5: Global: Nucleotides Market: Breakup by Technology (in %), 2023
Figure 6: Global: Nucleotides Market: Breakup by Form (in %), 2023
Figure 7: Global: Nucleotides Market: Breakup by Application (in %), 2023
Figure 8: Global: Nucleotides Market: Breakup by Region (in %), 2023
Figure 9: Global: Nucleotides (Food Grade) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Nucleotides (Food Grade) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Nucleotides (Lab Grade) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Nucleotides (Lab Grade) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Nucleotides (Industry Grade) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Nucleotides (Industry Grade) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Nucleotides (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Nucleotides (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Nucleotides (TaqMan Allelic Discrimination) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Nucleotides (TaqMan Allelic Discrimination) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Nucleotides (Gene Chips and Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Nucleotides (Gene Chips and Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Nucleotides (SNP by Pyrosequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Nucleotides (SNP by Pyrosequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Nucleotides (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Nucleotides (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Nucleotides (Liquid) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Nucleotides (Liquid) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Nucleotides (Powder) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Nucleotides (Powder) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Nucleotides (Pharmaceutical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Nucleotides (Pharmaceutical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Nucleotides (Food and Animal Feed Additives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Nucleotides (Food and Animal Feed Additives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Nucleotides (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Nucleotides (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Nucleotides (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Nucleotides (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Nucleotides Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Nucleotides Industry: SWOT Analysis
Figure 87: Global: Nucleotides Industry: Value Chain Analysis
Figure 88: Global: Nucleotides Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Nucleotides Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Nucleotides Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Nucleotides Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Nucleotides Market Forecast: Breakup by Form (in Million US$), 2024-2032
Table 5: Global: Nucleotides Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 6: Global: Nucleotides Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Nucleotides Market: Competitive Structure
Table 8: Global: Nucleotides Market: Key Players

02-2729-4219

+886-2-2729-4219